UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 6, 2010

 
 
NEPHROS, INC.
  
 
(Exact name of registrant as specified in its charter)
  

 
Delaware
 (State or other jurisdiction of incorporation)

 
 001-32288
  
13-3971809
 (Commission File Number)
  
(IRS Employer ID Number)

 
41 Grand Avenue, River Edge, New Jersey
07661
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code (201) 343-5202

__________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act   (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 8.01.  Other Events.
 
On July 6, 2010, Nephros, Inc. issued a press release announcing that AmeriWater has adopted the Nephros Dual Stage Ultrafilter as a standard component of AmeriWater’s MRO portable reverse osmosis water treatment systems for dialysis.  A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
 
Item 9.01. Financial Statements and Exhibits.

(d)           Exhibits

Exhibit No.
Description
   
99.1
Press release dated July 6, 2010.





 
2
 
SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  Nephros, Inc.  
     
       
 
By:
/s/ Gerald J. Kochanski
  
Dated:  July 6, 2010
  
Gerald J. Kochanski
  
   
Chief Financial Officer
  
 
 
 

 
 
3